XDH and hyperuricemia: Treatment with AICAR in vivo increases purine degradation and production of uric acid, leading to hyperuricemia, which can be prevented by inhibiting xanthine dehydrogenase with allopurinol [46, 47, 48, 49] (Figure 1A).